Annals of Vascular Surgery
Volume 21, Issue 6 , Pages 704-712 , November 2007

Ischemic Complications of Percutaneous Femoral Artery Catheterization

  • Paul M. Schumacher

      Affiliations

    • Department of Vascular Surgery, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Charles B. Ross

      Affiliations

    • Department of Vascular Surgery, Vanderbilt University Medical Center, Nashville, TN
    • Corresponding Author InformationCorrespondence to: Charles B. Ross, 1161 22nd Avenue South, D-5237 Medical Center North, Nashville, TN 37232-2735, USA
    • ,
  • Yi-Chen Wu

      Affiliations

    • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Rafe M. Donahue

      Affiliations

    • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Timothy J. Ranval

      Affiliations

    • Department of Vascular Surgery, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Jeffery B. Dattilo

      Affiliations

    • Department of Vascular Surgery, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Raul J. Guzman

      Affiliations

    • Department of Vascular Surgery, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Thomas C. Naslund

      Affiliations

    • Department of Vascular Surgery, Vanderbilt University Medical Center, Nashville, TN

References 

  1. Muller DW, Sharmir KJ, Ellis SG, et al. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol. 1992;69:63–68
  2. Popma JJ, Satler LI, Pichard AD, et al. Vascular complications after balloon and new device angioplasty. Circulation. 1993;88:1569–1578
  3. Moscucci M, Mansour KA, Kent KC, et al. Peripheral vascular complications of directional coronary atherectomy and stenting: predictors, management, and outcome. Am J Cardiol. 1994;74:448–453
  4. Nasser TK, Mohler ER, Wilensky RL, et al. Peripheral vascular complications following coronary interventional procedures. Clin Cardiol. 1994;18:609–614
  5. Duffin DC, Muhlestein JB, Allisson SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol. 2001;13:354–362
  6. Bogart MA. Time to hemostasis: a comparison of manual versus mechanical compression of the femoral artery. Am J Crit Care. 1995;4:149–156
  7. Slaughter PM, Chetty R, Flintoft VF, et al. A single center randomized trial assessing use of a vascular hemostasis device vs. conventional manual compression following PTCA: what are the potential resource savings?. Cathet Cardiovasc Diagn. 1995;34:210–214
  8. Baim DS, Knopf WD, Hinohara T, et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the Suture to Ambulate and Discharge (STAND I and STAND II) trials. Am J Cardiol. 2000;85:864–869
  9. Nasu K, Tsuchikane E, Sumitsuji S, et al. Clinical effectiveness of the Prostar XL suture-mediated percutaneous vascular closure device following PCI: results of the Perclose Accelerated Ambulation and Discharge (PARADISE) trial. J Invasive Cardiol. 2003;15:251–256
  10. Nasu K, Tsuchikane E, et al. The safety and efficacy of “pre-closure” utilizing the Closer suture-mediated vascular closure device for achievement of hemostasis in patients following coronary interventions: results of the second Perclose Accelerated Ambulation and Discharge (PARADISE II) trial. J Invasive Cardiol. 2005;17:30–33
  11. Eggebrecht H, Haude M, Woertgen U, et al. Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients. Catheter Cardiovasc Interv. 2002;57:486–495
  12. Thalhammer C, Aschwanden M, Jeanneret C, et al. Symptomatic vascular complications after vascular closure device use following diagnostic and interventional catheterization. Vasa. 2004;33:78–81
  13. Kirchhof C, Schickel S, Schmidt-Lucke C, et al. Local vascular complications after use of the hemostatic puncture closure device Angio-Seal. Vasa. 2002;31:101–106
  14. Dregelid E, Jensen G, Daryapeyma A. Complications associated with the Angio-Seal arterial puncture closing device: intra-arterial deployment and occlusion by dissected plaque. J Vasc Surg. 2006;44:1357–1359
  15. Meyerson SL, Feldman T, Desai TR, et al. Angiographic access site complications in the era of arterial closure devices. Vasc Endovasc Surg. 2002;36:137–144
  16. The SEAL Trial Study Team. Assessment of the safety and efficacy of the DUETT vascular hemostasis device: final results of the Safe and Effective Vascular Hemostasis (SEAL) trial. Am Heart J. 2002;143:612–619
  17. Michalis LK, Rees MR, Patsouras D, et al. A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal, and Duett). Cardiovasc Intervent Radiol. 2002;25:423–429
  18. Hermiller JB, Simonton C, Hinohara T, et al. The StarClose vascular closure system: interventional results from the CLIP study. Catheter CardiovascInterv. 2006;68:677–683
  19. Abando A, Hood D, Weaver F, et al. The use of the Angio-Seal device for femoral artery closure. J Vasc Surg. 2004;40:287–290
  20. Mackrell PJ, Kalbaugh CA, Langan EM, et al. Can the Perclose suture-mediated closure system be used safely in patients undergoing diagnostic and therapeutic angiography to treat chronic lower extremity ischemia?. J Vasc Surg. 2003;38:1305–1308
  21. Gonze MD, Sternbergh WC, Salartash K, et al. Complications associated with percutaneous closure devices. Am J Surg. 1999;178:209–211
  22. Eidt JF, Habibipour S, Saucedo JF, et al. Surgical complications from hemostatic puncture closure devices. Am J Surg. 1999;178:511–516
  23. Boston US, Panneton JM, Hofer JM, et al. Infectious and ischemic complications from percutaneous closure devices used after vascular access. Ann Vasc Surg. 2003;17:66–71
  24. Siani A, Schioppa A, Flaishman I, et al. Management of acute lower limb ischemia following percutaneous arterial closure device application: our experience. G Chir. 2006;27:119–122
  25. Biancari F, Ylönen K, Mosorin M, et al. Lower limb ischemic complications after the use of arterial puncture closure devices. Eur J Vasc Endovasc Surg. 2006;32:504–505
  26. Castelli P, Caronno R, Piffaretti G, et al. Incidence of vascular injuries after use of the Angio-Seal closure device following endovascular procedures in a single center. World J Surg. 2006;30:280–284
  27. Wille J, Vos JA, Overtoom T, et al. Acute leg ischemia: the dark side of a percutaneous femoral artery closure device. Ann Vasc Surg. 2006;20:278–281
  28. Jang JJ, Kim M, Gray B, et al. Claudication secondary to Perclose use after percutaneous procedures. Catheter Cardiovasc Interv. 2006;67:687–695
  29. Sprouse LR, Botta DM, Hamilton IN. The management of peripheral vascular complications associated with the use of percutaneous suture-mediated closure devices. J Vasc Surg. 2001;33:688–693
  30. Nehler MR, Lawrence WA, Whitehill TA, et al. Iatrogenic vascular injuries from percutaneous vascular suturing devices. J Vasc Surg. 2001;33:943–947
  31. Konstance R, Tcheng JE, Wightman MB, et al. Incidence and predictors of major vascular complications after percutaneous coronary intervention in the glycoprotein IIb/IIIa platelet inhibitor era. J Interv Cardiol. 2004;17:65–70
  32. Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65:196–202
  33. Piper WD, Malenka DJ, Ryan TJ, et al. Predicting vascular complications in percutaneous coronary interventions. Am Heart J. 2003;145:1022–1029
  34. Eggebrecht H, von Birgelen C, Naber C, et al. Impact of gender on femoral access complications secondary to application of a collagen-based vascular closure device. J Invasive Cardiol. 2004;16:247–250
  35. Tavris DR, Gallauresi BA, Dey S, et al. Risk of local adverse events by gender following cardiac catheterization. Pharmacoepidemiol Drug Saf. 2007;16:125–131
  36. Ratnam LA, Raja J, Munneke GJ, et al. Prospective nonrandomized trial of manual compression and Angio-Seal and Starclose arterial closure devices in common femoral punctures. Cardiovasc Intervent Radiol. 2007;30:182–188
  37. Messina LM, Brothers TE, Wakefield TW, et al. Clinical characteristics and surgical management of vascular complications in patients undergoing cardiac catheterization: interventional versus diagnostic procedures. J Vasc Surg. 1991;13:593–600
  38. Nikolsky E, Mehran R, Halkin A, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44:1200–1209
  39. Koreny M, Riedmüller E, Nikfardjam M, et al. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA. 2004;291:350–357
  40. Warren BS, Warren SG, Miller SD. Predictors of complications and learning curve using the Angio-Seal closure device following interventional and diagnostic catheterization. Catheter Cardiovasc Interv. 1999;48:162–166
  41. Shaw JA, Gravereaux EC, Winters GL, et al. An unusual cause of claudication. Catheter Cardiovasc Interv. 2003;60:562–565
  42. Rosenstein G, Cafri C, Weinstein JM, et al. Simple clinical risk stratification and the safety of ambulation two hours after 6 French diagnostic heart catheterization. J Invasive Cardiol. 2004;16:126–128
  43. Doyle BJ, Konz BA, Lennon RJ, et al. Ambulation 1 hour after diagnostic cardiac catheterization: a prospective study of 1009 procedures. Mayo Clin Proc. 2006;81:1537–1540

 Presented at the Annual Winter Meeting of the Peripheral Vascular Surgery Society, Steamboat Springs, CO, January 26-28, 2007.

PII: S0890-5096(07)00256-7

doi: 10.1016/j.avsg.2007.05.001

Annals of Vascular Surgery
Volume 21, Issue 6 , Pages 704-712 , November 2007

Article Tools

* Image Usage & Resolution